# Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.

> **NCT05909800** · PHASE2 · UNKNOWN · sponsor: **Medical University of Warsaw** · enrollment: 102 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Phenofibrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05909800
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-29
- **Primary completion:** 2024-07
- **Final completion:** 2024-07
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2023-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05909800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05909800, "Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05909800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*